Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities. Where to invest $1,000 right now? Our analyst ...

BMO Capital analyst Evan Seigerman maintained a Buy rating on Pfizer Inc. (NYSE:PFE) and kept the price target the same at ...

Pfizer will pay China’s 3SBio $1.25 billion up front to access a cancer drug that could rival Akeso and Summit’s closely ...

If you see a stock that pays 6% in dividends, you might assume it's too risky -- but that's not always the case. In some ...

Novavax, along with its competitors, will need to seek additional approval to alter the strain of the virus its vaccine ...

How many shares of Pfizer should you own to make $10,000 in annual dividend income? Where to invest $1,000 right now? Our ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

Announcement pressures pharma stocks on worries profits will be hit if they have to cut prices in US. Read more at ...

But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...

Protalix BioTherapeutics, Inc.’s PLX share price has dipped by 35.47%, which has investors questioning if this is right time to buy.